Bank of New York Mellon’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Sell |
77,407
-4,912
| -6% | -$97.7K | ﹤0.01% | 2871 |
|
|
2025
Q1 | $1.39M | Sell |
82,319
-67,579
| -45% | -$1.14M | ﹤0.01% | 2854 |
|
|
2024
Q4 | $2.77M | Sell |
149,898
-38,099
| -20% | -$704K | ﹤0.01% | 2597 |
|
|
2024
Q3 | $4.09M | Sell |
187,997
-13,204
| -7% | -$287K | ﹤0.01% | 2390 |
|
|
2024
Q2 | $3.95M | Buy |
201,201
+55,020
| +38% | +$1.08M | ﹤0.01% | 2450 |
|
|
2024
Q1 | $3.17M | Sell |
146,181
-9,748
| -6% | -$212K | ﹤0.01% | 2530 |
|
|
2023
Q4 | $4.51M | Sell |
155,929
-57,817
| -27% | -$1.67M | ﹤0.01% | 2421 |
|
|
2023
Q3 | $5.72M | Sell |
213,746
-7,770
| -4% | -$208K | ﹤0.01% | 2244 |
|
|
2023
Q2 | $8.2M | Sell |
221,516
-4,843
| -2% | -$179K | ﹤0.01% | 2046 |
|
|
2023
Q1 | $7.07M | Sell |
226,359
-5,052
| -2% | -$158K | ﹤0.01% | 2115 |
|
|
2022
Q4 | $6.89M | Sell |
231,411
-9,541
| -4% | -$284K | ﹤0.01% | 2148 |
|
|
2022
Q3 | $9.19M | Buy |
240,952
+10,342
| +4% | +$394K | ﹤0.01% | 1946 |
|
|
2022
Q2 | $12.6M | Sell |
230,610
-19,553
| -8% | -$1.07M | ﹤0.01% | 1806 |
|
|
2022
Q1 | $15.6M | Sell |
250,163
-1,483
| -0.6% | -$92.6K | ﹤0.01% | 1818 |
|
|
2021
Q4 | $25.3M | Buy |
251,646
+44,332
| +21% | +$4.46M | ﹤0.01% | 1583 |
|
|
2021
Q3 | $18.6M | Buy |
207,314
+13,890
| +7% | +$1.25M | ﹤0.01% | 1762 |
|
|
2021
Q2 | $17.8M | Buy |
193,424
+24,758
| +15% | +$2.28M | ﹤0.01% | 1798 |
|
|
2021
Q1 | $16.3M | Buy |
168,666
+32,183
| +24% | +$3.11M | ﹤0.01% | 1814 |
|
|
2020
Q4 | $7.11M | Buy |
136,483
+39,052
| +40% | +$2.03M | ﹤0.01% | 2182 |
|
|
2020
Q3 | $3.9M | Buy |
97,431
+23,372
| +32% | +$936K | ﹤0.01% | 2347 |
|
|
2020
Q2 | $1.19M | Buy |
74,059
+21,516
| +41% | +$344K | ﹤0.01% | 2994 |
|
|
2020
Q1 | $566K | Buy |
+52,543
| New | +$566K | ﹤0.01% | 3294 |
|
|
2017
Q2 | – | Sell |
-11,230
| Closed | -$122K | – | 4311 |
|
|
2017
Q1 | $122K | Buy |
+11,230
| New | +$122K | ﹤0.01% | 3976 |
|